Compare KOPN & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOPN | PMVP |
|---|---|---|
| Founded | 1984 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 424.9M | 68.9M |
| IPO Year | 1992 | 2020 |
| Metric | KOPN | PMVP |
|---|---|---|
| Price | $2.29 | $1.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $4.25 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 2.8M | 255.3K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $45,602,295.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $43.33 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.02 | N/A |
| 52 Week Low | $0.71 | $0.81 |
| 52 Week High | $4.16 | $1.84 |
| Indicator | KOPN | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 39.08 | 33.18 |
| Support Level | $2.40 | $1.14 |
| Resistance Level | $2.44 | $1.30 |
| Average True Range (ATR) | 0.19 | 0.07 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 11.48 | 2.08 |
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.